Overactivation of NLRP3 has been implicated in several pediatric inflammatory disorders, including asthma, juvenile idiopathic arthritis (JIA), and inflammatory bowel disease (IBD), all of which share a common pathway involving NLRP3 activation and cytokine-driven inflammation. Here, NLRP3 is linked to asthma.